Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Collins

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 2012
IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J miceAndrew L Rankin, Heath Guay, Deborah Herber, et al.
The Journal of Clinical Investigation|December 17, 2008
IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and miceHaoli Jin, Michiko K Oyoshi, Yi Le, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2012
The β-globin locus control region in combination with the EF1α short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activityClaudia A Montiel-Equihua, Lin Zhang, Sean Knight, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2014
TRIL is involved in cytokine production in the brain following Escherichia coli infectionPaulina Wochal, Vijay A K Rathinam, Aisling Dunne, et al.
Immunity|April 24, 2002
IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunityMarion T Kasaian, Matthew J Whitters, Laura L Carter, et al.
Rheumatology (Oxford, England)|January 25, 2011
Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeysCheryl Nickerson-Nutter, Lioudmila Tchistiakova, Nilufer P Seth, et al.
Scientific Reports|October 27, 2024
Engineered protein subunit COVID19 vaccine is as immunogenic as nanoparticles in mouse and hamster modelsMelissa M Matthews, Tae Gyun Kim, Keon Young Kim, et al.
Journal of Neuroimmunology|December 22, 2006
PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitisLaura L Carter, Michael W Leach, Mihai L Azoitei, et al.
Science (New York, N.Y.)|February 26, 2011
Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunityAnne Puel, Sophie Cypowyj, Jacinta Bustamante, et al.
Japanese Journal of Infectious Diseases|September 29, 2024
SARS-CoV-2 IgG Seroprevalence in the Okinawa Main Island and Remote Islands in Okinawa, Japan, 2020-2021Yoshihiro Takayama, Yusuke Shimakawa, Yoshiaki Aizawa, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 2012
IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J miceAndrew L Rankin, Heath Guay, Deborah Herber, et al.
The Journal of Clinical Investigation|December 17, 2008
IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and miceHaoli Jin, Michiko K Oyoshi, Yi Le, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2012
The β-globin locus control region in combination with the EF1α short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activityClaudia A Montiel-Equihua, Lin Zhang, Sean Knight, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2014
TRIL is involved in cytokine production in the brain following Escherichia coli infectionPaulina Wochal, Vijay A K Rathinam, Aisling Dunne, et al.
Immunity|April 24, 2002
IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunityMarion T Kasaian, Matthew J Whitters, Laura L Carter, et al.
Rheumatology (Oxford, England)|January 25, 2011
Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeysCheryl Nickerson-Nutter, Lioudmila Tchistiakova, Nilufer P Seth, et al.
Scientific Reports|October 27, 2024
Engineered protein subunit COVID19 vaccine is as immunogenic as nanoparticles in mouse and hamster modelsMelissa M Matthews, Tae Gyun Kim, Keon Young Kim, et al.
Journal of Neuroimmunology|December 22, 2006
PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitisLaura L Carter, Michael W Leach, Mihai L Azoitei, et al.
Science (New York, N.Y.)|February 26, 2011
Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunityAnne Puel, Sophie Cypowyj, Jacinta Bustamante, et al.
Japanese Journal of Infectious Diseases|September 29, 2024
SARS-CoV-2 IgG Seroprevalence in the Okinawa Main Island and Remote Islands in Okinawa, Japan, 2020-2021Yoshihiro Takayama, Yusuke Shimakawa, Yoshiaki Aizawa, et al.
Pageof 12